Addressing therapeutic advancements, this session focuses on pharmacological treatments, minimally invasive procedures (e.g., endoscopic therapy), and surgical interventions for gastrointestinal disorders. Discussions will highlight clinical trials, outcomes research, and novel therapeutic targets in inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and liver diseases. Innovations in therapy aim to improve patient quality of life, reduce treatment-related complications, and achieve better disease management outcomes. By discussing therapeutic breakthroughs and best practices, this session aims to foster collaboration between clinicians, researchers, and pharmaceutical developers to accelerate the translation of research findings into clinical practice and enhance patient care.